The epidemiology of Sphingobium yanoikuyae in humans isn’t well-studied. This bacterium rarely causes infections. Based on web searches, there’s only one reported human infection case. An 87-year-old patient on peritoneal dialysis for end-stage renal failure developed peritonitis. The infection source was likely environmental contamination or nosocomial transmission, especially in dialysis settings.
These aerobic, gram-negative bacteria can break down aromatic hydrocarbons and other pollutants. They’re found in freshwater, seawater, soil, and dialysis equipment. Sphingomonadaceae infections are uncommon, suggesting low virulence. However, they may cause nosocomial infections in immunocompromised or dialysis patients. Additionally, some Sphingomonadaceae strains resist aminoglycosides, cephalosporins, and penicillins. It raises concerns about antibiotic resistance in opportunistic bacteria like Sphingomonadaceae.
Kingdom: Bacteria
Phylum: Pseudomonadota
Class: Alphaproteobacteria
Order: Sphingomonadales
Family: Sphingomonadaceae
Genus:Sphingobium
Species: Sphingobium yanoikuyae
Sphingobium yanoikuyae is a bacterium in the Pseudomonadota phylum. It has some unique traits:
This microbe appears yellow or off-white. It needs oxygen and has a short rod shape. Though Gram-negative, it lacks the toxins typically found in such bacteria.
Cell Wall: Surprisingly, it doesn’t contain lipopolysaccharides (LPS), the endotoxins common in non-Gram-negative organisms. Instead, it has hydrophobic glycosphingolipids (GSLs). These may help it resist drugs and evade the immune system.
Membrane: Its cell membrane has phospholipids, proteins, and respiratory quinones. The outer membrane contains GSLs.
Metabolism: Sphingobium yanoikuyae can break down aromatic compounds and polycyclic aromatic hydrocarbons (PAHs) – harmful environmental pollutants. It also uses various organic substances and carbon sources like L-arabinose, D-xylose, galactose, Salicin, mannose, D-turanose, and caprate.
Sphingobium yanoikuyae rarely causes infections in humans. So, we don’t have much information about its antigenic types in humans.
The antigenic types might depend on the bacteria’s ability to cause disease. But more research is needed to understand this bacteria’s virulence factors and how it interacts with the human immune system at a molecular level.
The way Sphingobium yanoikuyae affects people isn’t very clear. It rarely causes infections in humans. But based on online info, some possible ways it could infect and make someone sick are:
S. yanoikuyae might get into the body through wounds, catheters, or dialysis equipment. It is more likely in people with weakened immune systems or those on peritoneal dialysis. Once inside, the bacteria could grow and spread, leading to infections like peritonitis, blood infections, heart valve infections, brain infections, or bone infections.
Instead of having a cell wall with lipopolysaccharides like most gram-negative bacteria, S. yanoikuyae has glycosphingolipids (GSLs). These molecules might help the bacteria resist the body’s immune defenses and antibiotics. Also, GSLs could change how the body’s cells trigger inflammation and produce cytokines.
S. yanoikuyae can destroy chemicals like polycyclic aromatic hydrocarbons found in nature. Some PAHs harm people. The bacteria may eat these chemicals, making toxic wastes that damage cells. Breaking PAHs can also stress cells through reactive oxygen, further hurting them. S. yanoikuyae might use PAHs as food, but this process harms cells.
S. yanoikuyae has an unusual cell wall – it lacks the lipopolysaccharides found in many gram-negative bacteria, which trigger immune responses. Instead, it contains glycosphingolipids (GSLs), water-repelling molecules. GSLs may let the bacteria resist immunity and antibiotics, change how host cells get inflamed, and produce cytokines.
The bacterium can break down polycyclic aromatic hydrocarbons and aromatic compounds. These pollute environments and harm human health. S. yanoikuyae might make metabolites using PAHs as food sources. These metabolites could be poisonous or cause mutations in our cells. Degrading PAHs may also generate reactive oxygen species. These species are able to oxidatively damage host cells.
S. yanoikuyae promotes root growth and higher plant biomass, potentially benefiting human health. For instance, it may protect against estrogen receptor-positive breast cancers by modulating estrogen receptor signaling, though further research must confirm this hypothesis.
Sphingobium yanoikuyae infection symptoms vary based on location and severity. Peritonitis, inflammation of the abdominal cavity lining, is most common. Causing abdominal pain, fever, nausea, vomiting, and cloudy dialysis fluid. Other possibilities: Bacteremia (blood infection).
Endocarditis (heart infection). Meningitis (brain infection). Osteomyelitis (bone infection). Symptoms differ depending on the infection site and intensity.
Diagnosing Sphingobium yanoikuyae infections in humans is tricky. It rarely causes disease. To diagnose, you can:
Grow the bacteria from infected areas like blood, peritoneal fluid, or cerebrospinal fluid. But identifying it is hard. Its biochemical and molecular traits differ from other gram-negative bacteria. Advanced methods like mass spectrometry or DNA sequencing may be needed to confirm.
Do an antibiogram to check its antibiotic sensitivity. It may resist common antibiotics.
Sphingobium yanoikuyae rarely infects humans, but preventive steps are still important. We must exercise extreme hygiene and sterilize dialysis equipment carefully. These bacteria can enter the body through wounds, catheters, or unclean dialysis machinery, especially for those with weakened immunity or undergoing peritoneal dialysis.
Avoid contact with contaminants like pentachlorophenol, PCBs, herbicides, and creosote. These pollutants may harbor or break into the bacteria, potentially harming health.
Researchers monitor breast microbiota intently. Some evidence suggests Sphingobium yanoikuyae could play a protective role against estrogen positive breast cancers by modulating estrogen receptor signaling pathways. However, confirming this hypothesis demands additional rigorous study and validation.
The epidemiology of Sphingobium yanoikuyae in humans isn’t well-studied. This bacterium rarely causes infections. Based on web searches, there’s only one reported human infection case. An 87-year-old patient on peritoneal dialysis for end-stage renal failure developed peritonitis. The infection source was likely environmental contamination or nosocomial transmission, especially in dialysis settings.
These aerobic, gram-negative bacteria can break down aromatic hydrocarbons and other pollutants. They’re found in freshwater, seawater, soil, and dialysis equipment. Sphingomonadaceae infections are uncommon, suggesting low virulence. However, they may cause nosocomial infections in immunocompromised or dialysis patients. Additionally, some Sphingomonadaceae strains resist aminoglycosides, cephalosporins, and penicillins. It raises concerns about antibiotic resistance in opportunistic bacteria like Sphingomonadaceae.
Kingdom: Bacteria
Phylum: Pseudomonadota
Class: Alphaproteobacteria
Order: Sphingomonadales
Family: Sphingomonadaceae
Genus:Sphingobium
Species: Sphingobium yanoikuyae
Sphingobium yanoikuyae is a bacterium in the Pseudomonadota phylum. It has some unique traits:
This microbe appears yellow or off-white. It needs oxygen and has a short rod shape. Though Gram-negative, it lacks the toxins typically found in such bacteria.
Cell Wall: Surprisingly, it doesn’t contain lipopolysaccharides (LPS), the endotoxins common in non-Gram-negative organisms. Instead, it has hydrophobic glycosphingolipids (GSLs). These may help it resist drugs and evade the immune system.
Membrane: Its cell membrane has phospholipids, proteins, and respiratory quinones. The outer membrane contains GSLs.
Metabolism: Sphingobium yanoikuyae can break down aromatic compounds and polycyclic aromatic hydrocarbons (PAHs) – harmful environmental pollutants. It also uses various organic substances and carbon sources like L-arabinose, D-xylose, galactose, Salicin, mannose, D-turanose, and caprate.
Sphingobium yanoikuyae rarely causes infections in humans. So, we don’t have much information about its antigenic types in humans.
The antigenic types might depend on the bacteria’s ability to cause disease. But more research is needed to understand this bacteria’s virulence factors and how it interacts with the human immune system at a molecular level.
The way Sphingobium yanoikuyae affects people isn’t very clear. It rarely causes infections in humans. But based on online info, some possible ways it could infect and make someone sick are:
S. yanoikuyae might get into the body through wounds, catheters, or dialysis equipment. It is more likely in people with weakened immune systems or those on peritoneal dialysis. Once inside, the bacteria could grow and spread, leading to infections like peritonitis, blood infections, heart valve infections, brain infections, or bone infections.
Instead of having a cell wall with lipopolysaccharides like most gram-negative bacteria, S. yanoikuyae has glycosphingolipids (GSLs). These molecules might help the bacteria resist the body’s immune defenses and antibiotics. Also, GSLs could change how the body’s cells trigger inflammation and produce cytokines.
S. yanoikuyae can destroy chemicals like polycyclic aromatic hydrocarbons found in nature. Some PAHs harm people. The bacteria may eat these chemicals, making toxic wastes that damage cells. Breaking PAHs can also stress cells through reactive oxygen, further hurting them. S. yanoikuyae might use PAHs as food, but this process harms cells.
S. yanoikuyae has an unusual cell wall – it lacks the lipopolysaccharides found in many gram-negative bacteria, which trigger immune responses. Instead, it contains glycosphingolipids (GSLs), water-repelling molecules. GSLs may let the bacteria resist immunity and antibiotics, change how host cells get inflamed, and produce cytokines.
The bacterium can break down polycyclic aromatic hydrocarbons and aromatic compounds. These pollute environments and harm human health. S. yanoikuyae might make metabolites using PAHs as food sources. These metabolites could be poisonous or cause mutations in our cells. Degrading PAHs may also generate reactive oxygen species. These species are able to oxidatively damage host cells.
S. yanoikuyae promotes root growth and higher plant biomass, potentially benefiting human health. For instance, it may protect against estrogen receptor-positive breast cancers by modulating estrogen receptor signaling, though further research must confirm this hypothesis.
Sphingobium yanoikuyae infection symptoms vary based on location and severity. Peritonitis, inflammation of the abdominal cavity lining, is most common. Causing abdominal pain, fever, nausea, vomiting, and cloudy dialysis fluid. Other possibilities: Bacteremia (blood infection).
Endocarditis (heart infection). Meningitis (brain infection). Osteomyelitis (bone infection). Symptoms differ depending on the infection site and intensity.
Diagnosing Sphingobium yanoikuyae infections in humans is tricky. It rarely causes disease. To diagnose, you can:
Grow the bacteria from infected areas like blood, peritoneal fluid, or cerebrospinal fluid. But identifying it is hard. Its biochemical and molecular traits differ from other gram-negative bacteria. Advanced methods like mass spectrometry or DNA sequencing may be needed to confirm.
Do an antibiogram to check its antibiotic sensitivity. It may resist common antibiotics.
Sphingobium yanoikuyae rarely infects humans, but preventive steps are still important. We must exercise extreme hygiene and sterilize dialysis equipment carefully. These bacteria can enter the body through wounds, catheters, or unclean dialysis machinery, especially for those with weakened immunity or undergoing peritoneal dialysis.
Avoid contact with contaminants like pentachlorophenol, PCBs, herbicides, and creosote. These pollutants may harbor or break into the bacteria, potentially harming health.
Researchers monitor breast microbiota intently. Some evidence suggests Sphingobium yanoikuyae could play a protective role against estrogen positive breast cancers by modulating estrogen receptor signaling pathways. However, confirming this hypothesis demands additional rigorous study and validation.
The epidemiology of Sphingobium yanoikuyae in humans isn’t well-studied. This bacterium rarely causes infections. Based on web searches, there’s only one reported human infection case. An 87-year-old patient on peritoneal dialysis for end-stage renal failure developed peritonitis. The infection source was likely environmental contamination or nosocomial transmission, especially in dialysis settings.
These aerobic, gram-negative bacteria can break down aromatic hydrocarbons and other pollutants. They’re found in freshwater, seawater, soil, and dialysis equipment. Sphingomonadaceae infections are uncommon, suggesting low virulence. However, they may cause nosocomial infections in immunocompromised or dialysis patients. Additionally, some Sphingomonadaceae strains resist aminoglycosides, cephalosporins, and penicillins. It raises concerns about antibiotic resistance in opportunistic bacteria like Sphingomonadaceae.
Kingdom: Bacteria
Phylum: Pseudomonadota
Class: Alphaproteobacteria
Order: Sphingomonadales
Family: Sphingomonadaceae
Genus:Sphingobium
Species: Sphingobium yanoikuyae
Sphingobium yanoikuyae is a bacterium in the Pseudomonadota phylum. It has some unique traits:
This microbe appears yellow or off-white. It needs oxygen and has a short rod shape. Though Gram-negative, it lacks the toxins typically found in such bacteria.
Cell Wall: Surprisingly, it doesn’t contain lipopolysaccharides (LPS), the endotoxins common in non-Gram-negative organisms. Instead, it has hydrophobic glycosphingolipids (GSLs). These may help it resist drugs and evade the immune system.
Membrane: Its cell membrane has phospholipids, proteins, and respiratory quinones. The outer membrane contains GSLs.
Metabolism: Sphingobium yanoikuyae can break down aromatic compounds and polycyclic aromatic hydrocarbons (PAHs) – harmful environmental pollutants. It also uses various organic substances and carbon sources like L-arabinose, D-xylose, galactose, Salicin, mannose, D-turanose, and caprate.
Sphingobium yanoikuyae rarely causes infections in humans. So, we don’t have much information about its antigenic types in humans.
The antigenic types might depend on the bacteria’s ability to cause disease. But more research is needed to understand this bacteria’s virulence factors and how it interacts with the human immune system at a molecular level.
The way Sphingobium yanoikuyae affects people isn’t very clear. It rarely causes infections in humans. But based on online info, some possible ways it could infect and make someone sick are:
S. yanoikuyae might get into the body through wounds, catheters, or dialysis equipment. It is more likely in people with weakened immune systems or those on peritoneal dialysis. Once inside, the bacteria could grow and spread, leading to infections like peritonitis, blood infections, heart valve infections, brain infections, or bone infections.
Instead of having a cell wall with lipopolysaccharides like most gram-negative bacteria, S. yanoikuyae has glycosphingolipids (GSLs). These molecules might help the bacteria resist the body’s immune defenses and antibiotics. Also, GSLs could change how the body’s cells trigger inflammation and produce cytokines.
S. yanoikuyae can destroy chemicals like polycyclic aromatic hydrocarbons found in nature. Some PAHs harm people. The bacteria may eat these chemicals, making toxic wastes that damage cells. Breaking PAHs can also stress cells through reactive oxygen, further hurting them. S. yanoikuyae might use PAHs as food, but this process harms cells.
S. yanoikuyae has an unusual cell wall – it lacks the lipopolysaccharides found in many gram-negative bacteria, which trigger immune responses. Instead, it contains glycosphingolipids (GSLs), water-repelling molecules. GSLs may let the bacteria resist immunity and antibiotics, change how host cells get inflamed, and produce cytokines.
The bacterium can break down polycyclic aromatic hydrocarbons and aromatic compounds. These pollute environments and harm human health. S. yanoikuyae might make metabolites using PAHs as food sources. These metabolites could be poisonous or cause mutations in our cells. Degrading PAHs may also generate reactive oxygen species. These species are able to oxidatively damage host cells.
S. yanoikuyae promotes root growth and higher plant biomass, potentially benefiting human health. For instance, it may protect against estrogen receptor-positive breast cancers by modulating estrogen receptor signaling, though further research must confirm this hypothesis.
Sphingobium yanoikuyae infection symptoms vary based on location and severity. Peritonitis, inflammation of the abdominal cavity lining, is most common. Causing abdominal pain, fever, nausea, vomiting, and cloudy dialysis fluid. Other possibilities: Bacteremia (blood infection).
Endocarditis (heart infection). Meningitis (brain infection). Osteomyelitis (bone infection). Symptoms differ depending on the infection site and intensity.
Diagnosing Sphingobium yanoikuyae infections in humans is tricky. It rarely causes disease. To diagnose, you can:
Grow the bacteria from infected areas like blood, peritoneal fluid, or cerebrospinal fluid. But identifying it is hard. Its biochemical and molecular traits differ from other gram-negative bacteria. Advanced methods like mass spectrometry or DNA sequencing may be needed to confirm.
Do an antibiogram to check its antibiotic sensitivity. It may resist common antibiotics.
Sphingobium yanoikuyae rarely infects humans, but preventive steps are still important. We must exercise extreme hygiene and sterilize dialysis equipment carefully. These bacteria can enter the body through wounds, catheters, or unclean dialysis machinery, especially for those with weakened immunity or undergoing peritoneal dialysis.
Avoid contact with contaminants like pentachlorophenol, PCBs, herbicides, and creosote. These pollutants may harbor or break into the bacteria, potentially harming health.
Researchers monitor breast microbiota intently. Some evidence suggests Sphingobium yanoikuyae could play a protective role against estrogen positive breast cancers by modulating estrogen receptor signaling pathways. However, confirming this hypothesis demands additional rigorous study and validation.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
